TotalMarketCap

Tiziana Life Sciences

TLSANasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$79.346 M

$0.62 -2.27%

Close of 6 Nov 2026

As of 6 Nov 2026, Tiziana Life Sciences (TLSA) has a market capitalization of $79.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

120,507,401

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #302Retension PharmaceuticalsRTSN$83.4M
  2. #303GeneluxGNLX$82.3M
  3. #304Tiziana Life SciencesTLSA$79.3M
  4. #305Tonix PharmaceuticalsTNXP$79.0M
  5. #306Cumberland PharmaceuticalsCPIX$75.5M

What if Tiziana Life Sciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$221,884.86

Per share 355,870× higher

Bitcoin $1.53T

$12,005.80

Per share 19,255× higher

Apple $5.02T

$39,413.93

Per share 63,214× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Tiziana Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.